Arkolith/Insider Trading/LTRN/Form 4

BIOS Fund II QP, LP

10% OwnerLantern Pharma Inc. (LTRN) · full profile →Form 4 · filed Jun 13, 2025
Net Selling
Open-Market Buys
$0
Open-Market Sells
$124K
Net Open-Market Flow
-$124K
Transactions
5
5 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Jun 13, 2025Sell(S)12K$3.09$38K323K
Jun 13, 2025Sell(S)4K$3.09$13K114K
Jun 13, 2025Sell(S)2K$3.09$6K50K
Jun 13, 2025Sell(S)14K$3.09$44K373K
Jun 13, 2025Sell(S)7K$3.09$22K189K

Transaction Codes

S
Open-market sale

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001104659-25-059528) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML